Ultra-Sensitive Nanoplatform for Detection of Brain-Derived Neurotrophic Factor Using Silica-Coated Gold Nanoparticles with Enzyme-Formed Quantum Dots
Molecules · 2025
DOI: 10.3390/molecules30030699 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Seona Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Chemical Engineering and Bioengineering, College of Art, Culture and Engineering, Kangwon National University, Chuncheon-si 24341, Republ…. Hauptthemen laut MEDLINE: Quantum Dots, Gold, Silicon Dioxide, Metal Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea Technology and Information Promotion Agency for SMEs, Development of Core Technologies for Platforms to Respond to Emerging and Re-emerging Infectious Diseases Project.
Abstract (Originalsprache)
A fluorescence-based detection platform was developed for brain-derived neurotrophic factor (BDNF), a key biomarker of Alzheimer’s disease (AD). This platform utilizes localized surface plasmon resonance effects resulting from the interactions between silica-coated gold nanoparticles (Au@SiO2) and enzymatically synthesized quantum dots (QDs). The gold nanoparticles were silica coated via the hydrolysis of tetraethyl orthosilicate, which allowed for precise control over the distance between the nanoparticles and QDs and refined the dynamics of fluorescence quenching and enhancement. Antibody conjugation was performed via sequential amination and carboxylation, followed by EDC/NHS coupling. BDNF was detected across a range of concentrations, from 1 ng/mL to 1 ng/mL, using an alkaline phosphatase (ALP)-conjugated polyclonal antibody targeting a secondary epitope of BDNF. The enzymatic hydrolysis of p-nitrophenyl phosphate by immobilized ALP led to the formation of cadmium sulfide QDs, with the fluorescence intensity correlating directly with the BDNF concentration. This platform offers a refined and precise method for detecting BDNF and is a reliable tool for the early diagnosis of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Chemical Engineering and Bioengineering, College of Art, Culture and Engineering, Kangwon National University, Chuncheon-si 24341, Republic of Korea.
- Department of Smart Health Science and Technology, Kangwon National University, Chuncheon-si 24341, Republic of Korea.
- YUHS-KRIBB Medical Convergence Research Institute, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
- Graduate Program of Biomedical Engineering, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
ORCID-Profile: Yu-Rim Ahn, Hwunjae Lee, Hyun-Ouk Kim
Förderung
- National Research Foundation of Korea
- Korea Technology and Information Promotion Agency for SMEs
- Development of Core Technologies for Platforms to Respond to Emerging and Re-emerging Infectious Diseases Project
Zitieren
APA
Yu, S., Choi, J., Ahn, Y. R., Kim, M., Kim, N., Lee, H., & Kim, H. O. (2025). Ultra-Sensitive Nanoplatform for Detection of Brain-Derived Neurotrophic Factor Using Silica-Coated Gold Nanoparticles with Enzyme-Formed Quantum Dots. Molecules. https://doi.org/10.3390/molecules30030699
Vancouver
Yu S, Choi J, Ahn YR, Kim M, Kim N, Lee H, et al. Ultra-Sensitive Nanoplatform for Detection of Brain-Derived Neurotrophic Factor Using Silica-Coated Gold Nanoparticles with Enzyme-Formed Quantum Dots. Molecules. 2025. doi:10.3390/molecules30030699
BibTeX
@article{Yu2025,
author = {Yu, Seona and Choi, Jaewon and Ahn, Yu-Rim and Kim, Minse and Kim, Nanhyeon and Lee, Hwunjae and Kim, Hyun-Ouk},
title = {Ultra-Sensitive Nanoplatform for Detection of Brain-Derived Neurotrophic Factor Using Silica-Coated Gold Nanoparticles with Enzyme-Formed Quantum Dots},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30030699}
}
EUVIMED